SA study to assess Pfizer, J&J boosters for patients with HI

Wits Reproductive Health and HIV Institute vaccine trial will examine the safety and impact of varying doses of the shots as boosters for people with HIV and the wider population

Related Keywords

Cape Town , Western Cape , South Africa , Johannesburg , Gauteng , Durban , Kwazulu Natal , South African , , Pfizer , Astrazeneca , Sinovac Biotech , Wits Reproductive Health , Johnson , Lee Fairlie , Booster After Sisonke Study , Safety , J Amp , Hiv Aids , Wits Reproductive Health And Hiv Institute , Vaccine Trial , Booster Shots , Covid Booster Shots , Immunogenicity , Usiness Live ,